Endo Shareholders Fight Bid To Nix Generic Price-Fixing Suit
By Matthew Perlman ( October 29, 2018, 7:04 PM EDT) -- A proposed class of Endo Pharmaceuticals shareholders has asked a Pennsylvania federal judge to reject the company's bid to dismiss a suit claiming the drugmaker inflated stock prices by concealing a conspiracy to fix the prices of generic drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.